CN102670833A - Mulberry twig and rehmannia root Chinese medicinal oral solution for relieving rheumatoid arthritis and preparation method of mulberry twig and rehmannia root Chinese medicinal oral solution - Google Patents

Mulberry twig and rehmannia root Chinese medicinal oral solution for relieving rheumatoid arthritis and preparation method of mulberry twig and rehmannia root Chinese medicinal oral solution Download PDF

Info

Publication number
CN102670833A
CN102670833A CN2012101820973A CN201210182097A CN102670833A CN 102670833 A CN102670833 A CN 102670833A CN 2012101820973 A CN2012101820973 A CN 2012101820973A CN 201210182097 A CN201210182097 A CN 201210182097A CN 102670833 A CN102670833 A CN 102670833A
Authority
CN
China
Prior art keywords
parts
chinese medicinal
oral solution
mulberry twig
rehmannia root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012101820973A
Other languages
Chinese (zh)
Other versions
CN102670833B (en
Inventor
黄芸
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong seven Tourism Development Co., Ltd.
Original Assignee
黄芸
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 黄芸 filed Critical 黄芸
Priority to CN 201210182097 priority Critical patent/CN102670833B/en
Publication of CN102670833A publication Critical patent/CN102670833A/en
Application granted granted Critical
Publication of CN102670833B publication Critical patent/CN102670833B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention discloses a mulberry twig and rehmannia root Chinese medicinal oral solution for relieving rheumatoid arthritis and a preparation method of the mulberry twig and rehmannia root Chinese medicinal oral solution. The mulberry twig and rehmannia root Chinese medicinal oral solution is prepared by, by weight, 50-150 parts of radix gentianae macrophyllae, 50-150 parts of radix stephaniae tetrandrae, 50-150 parts of Chinese taxilus herbs, 200-400 parts of mulberry twig, 200-400 parts of rehmannia roots, 50-150 parts of pinenut kernels and 50-150 parts of honeysuckle stems. The mulberry twig and rehmannia root Chinese medicinal oral solution has the advantages of being good in healing effects for patients, small in toxic and side effects, capable of treating both principal and secondary aspects of diseases, strengthening healthy energy and eliminating pathogen, free from stagnating pathogen and hurting the healthy energy, low in cost and applicable to clinical popularization and application, and by means of the mulberry twig and rehmannia root Chinese medicinal oral solution, diseases are recurrence-free.

Description

Rheumatoid arthritis Ramulus Mori Radix Rehmanniae Chinese medicine oral liquid and method for preparing
Technical field
The invention belongs to the field of Chinese medicines, particularly a kind of rheumatoid arthritis Ramulus Mori Radix Rehmanniae Chinese medicine oral liquid and method for preparing.
Background technology
Rheumatoid arthritis (RA) is mainly to show as symmetric multi-joint chronic inflammation disease on every side, be a kind of be master's autoimmune disease with the chronic progressive external arthropathy, wrist, elbow, knee joint, ankle and joints of foot Chang Yi are symmetry and get involved.Infection and autoimmune response are the key links of RA morbidity and state of an illness delay, and endocrine, heredity and environmental factors etc. have then increased the susceptibility of RA.Theory of Chinese medical science is thought: positive QI-insufficiency, and caused by liver and kidney deficiency, muscles and bones is not strong, and interspaces of skin and muscles being loose, weakened defensive QI are the intrinsic factor that cause RA; Exopathogenic factor is the damp and hot heresy invasion and attack of wind and cold.Disease is prone to into network for a long time, and causes blood stasis resistance network, thus wind, wet, heat, tremble with fear, the stasis of blood, void be its main pathological factor.Chinese medicine is used to treat the medicine of rheumatoid arthritis, owing to have little, the eutherapeutic characteristics of side effect, so favored by people.
Summary of the invention
The object of the present invention is to provide little, the good effect of a kind of side effect, be used for rheumatoid arthritis Ramulus Mori Radix Rehmanniae Chinese medicine oral liquid and method for preparing.
For realizing above-mentioned purpose, the present invention realizes through following technical scheme:
Rheumatoid arthritis Ramulus Mori Radix Rehmanniae Chinese medicine oral liquid is to be processed by the crude drug of following parts by weight:
Radix Gentianae Macrophyllae 50-150 part, Radix Stephaniae Tetrandrae 50-150 part, Herba Taxilli 50-150 part, Ramulus Mori 200-400 part, Radix Rehmanniae 200-400 part, Semen pini koraiensis 50-150 part, Caulis Lonicerae 50-150 part.
Described rheumatoid arthritis Ramulus Mori Radix Rehmanniae Chinese medicine oral liquid is to be processed by the crude drug of following parts by weight:
100 parts of Radix Gentianae Macrophyllae, 100 parts of Radixs Stephaniae Tetrandrae, 100 parts of Herba Taxillis, 300 parts of Ramulus Moris, 300 parts in the Radix Rehmanniae, 100 parts of Semen pini koraiensis, 100 parts of Caulis Loniceraes.
Described rheumatoid arthritis Ramulus Mori Radix Rehmanniae Chinese medicine oral liquid and method for preparing comprise the following steps:
Get it filled 100 parts of material Radix Gentianae Macrophyllae, 100 parts of Radixs Stephaniae Tetrandrae, 100 parts of Herba Taxillis, 300 parts of Ramulus Moris, 300 parts in the Radix Rehmanniae, 100 parts of Semen pini koraiensis, 100 parts of Caulis Loniceraes, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Instructions of taking: every day early, middle and late respectively taking once, a dose is 20ml, 30 days is a course of treatment, takes medicine that the back is many took effect at 5 days, 3-6 the healing course of treatment.This Chinese medicine oral liquid characteristics are that the patient is fully recovered is effective, and toxic and side effects is little, play treating both the principal and secondary aspects of a disease, set upright evil, the eliminating evil positive effect of not hindering that do not stagnate, and do not have recurrence, and cost is low, is worth clinical application.
In the raw material of Chinese medicine that the present invention selected for use, Radix Gentianae Macrophyllae: bitter, hot, be slightly cold, return stomach, liver, gallbladder meridian, wind-damp dispelling, channels sootheing and network vessel quickening, clearind deficient heat; Radix Stephaniae Tetrandrae: bitter, hot, cold, return bladder, kidney, spleen channel, wind-damp dispelling, pain relieving, diuretic; Herba Taxilli: bitter, sweet, flat, return liver, kidney channel, wind-damp dispelling, liver and kidney tonifying, bone and muscle strengthening, antiabortive; Ramulus Mori: little hardship, flat, return Liver Channel, wind-damp dispelling, sharp joint, be used to take on arm, joint aches is numb; The Radix Rehmanniae: sweet, bitter, cold, GUIXIN, liver, kidney channel, clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting; Semen pini koraiensis: sweet, tepor, return liver, lung, large intestine channel, moisturize, nourish blood, dispel the wind; Caulis Lonicerae: cold, sweet, flat, attach to the lung and stomach meridians heat-clearing and toxic substances removing, dispelling wind collateral dredging.Theory of Chinese medical science is thought: positive QI-insufficiency, and caused by liver and kidney deficiency, muscles and bones is not strong, and interspaces of skin and muscles being loose, weakened defensive QI are the intrinsic factor that cause rheumatoid arthritis; Exopathogenic factor is the damp and hot heresy invasion and attack of wind and cold.Disease is prone to into network for a long time, and causes blood stasis resistance network, thus wind, wet, heat, tremble with fear, the stasis of blood, void be its main pathological factor.The catabasis eliminating pathogenic factor for supporting vital QI is the rule of treatment; We are method of treatment with expelling wind and removing dampness heat clearing away cold expelling, liver and kidney tonifying, benefiting qi and nourishing blood, blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, removing obstruction in the collateral to relieve pain; All medicines share, and play expelling wind and removing dampness, clearing heat for detumescence, cold expelling collateral dredging, relaxing muscles and tendons to promote blood circulation altogether, fill blood, the merit of liver and kidney tonifying, eliminating impediment pain relieving.Oral liquid of the present invention can effectively be removed the symptom of the arthralgia due to the rheumatoid arthritis, and specially medicine is specially controlled, and is evident in efficacy.Points for attention: anemia of pregnant woman's forbidding.
The specific embodiment
EXAMPLE l:
Crude drug: 100 parts of Radix Gentianae Macrophyllae, 100 parts of Radixs Stephaniae Tetrandrae, 100 parts of Herba Taxillis, 300 parts of Ramulus Moris, 300 parts in the Radix Rehmanniae, 100 parts of Semen pini koraiensis, 100 parts of Caulis Loniceraes.
Method for making: 100 parts of the material Radix Gentianae Macrophyllae of getting it filled, 100 parts of Radixs Stephaniae Tetrandrae, 100 parts of Herba Taxillis, 300 parts of Ramulus Moris, 300 parts in the Radix Rehmanniae, 100 parts of Semen pini koraiensis, 100 parts of Caulis Loniceraes, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Embodiment 2:
Crude drug: 150 parts of Radix Gentianae Macrophyllae, 150 parts of Radixs Stephaniae Tetrandrae, 150 parts of Herba Taxillis, 400 parts of Ramulus Moris, 400 parts in the Radix Rehmanniae, 150 parts of Semen pini koraiensis, 150 parts of Caulis Loniceraes.
Method for making: 150 parts of the material Radix Gentianae Macrophyllae of getting it filled, 150 parts of Radixs Stephaniae Tetrandrae, 150 parts of Herba Taxillis, 400 parts of Ramulus Moris, 400 parts in the Radix Rehmanniae, 150 parts of Semen pini koraiensis, 150 parts of Caulis Loniceraes, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Embodiment 3:
Crude drug: 50 parts of Radix Gentianae Macrophyllae, 50 parts of Radixs Stephaniae Tetrandrae, 50 parts of Herba Taxillis, 200 parts of Ramulus Moris, 200 parts in the Radix Rehmanniae, 50 parts of Semen pini koraiensis, 50 parts of Caulis Loniceraes.
Method for making: 50 parts of the material Radix Gentianae Macrophyllae of getting it filled, 50 parts of Radixs Stephaniae Tetrandrae, 50 parts of Herba Taxillis, 200 parts of Ramulus Moris, 200 parts in the Radix Rehmanniae, 50 parts of Semen pini koraiensis, 50 parts of Caulis Loniceraes, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
Embodiment 4:
1, clinical trial: 65 routine rheumatoid arthritis patients are carried out clinical observation alleviate, the age 30 is by 75 years old, the course of disease 1 year 1 years.
2, Therapeutic Method: take the made Chinese medicine oral liquid of embodiment of the invention l, every day early, middle and late respectively taking once, a dose is 20ml, 30 days is a course of treatment.
3, treatment standard:
Cure in the recent period: arthralgia and swelling disappear, and moving obstacle and both hands grip return to normal basically.
Produce effects: arthralgia and swelling disappear, and moving obstacle and both hands grip are recovered to have clear improvement.
Effectively: patient's self evaluation has improvement, the joint sx of getting involved.
Invalid: symptom no change before and after the treatment.
4, therapeutic effect: clinical 70 examples, cure 45 examples in the recent period, produce effects 10 examples, effective 6 examples, invalid 4 examples, total effective rate 93.8%.
Embodiment 5:
Model case: the field, the man, 40 years old, suffered from rheumatoid arthritis 3 years, take the made Chinese medicine oral liquid of embodiment of the invention l, every day early, middle and late respectively taking once, a dose is 20ml, 30 days is a course of treatment, cure two courses of treatment.
Embodiment 6:
Model case: together certain, the woman, 55 years old, suffered from rheumatoid arthritis 6 years, take the made Chinese medicine oral liquid of embodiment of the invention l, every day early, middle and late respectively taking once, a dose is 20ml, 30 days is a course of treatment, cure four courses of treatment.
Embodiment 7:
Model case: the hole, the man, 67 years old, suffered from rheumatoid arthritis 5 years, take the made Chinese medicine oral liquid of embodiment of the invention l, every day early, middle and late respectively taking once, a dose is 20ml, 30 days is a course of treatment, cure three courses of treatment.

Claims (3)

1. rheumatoid arthritis Ramulus Mori Radix Rehmanniae Chinese medicine oral liquid is characterized in that: be to be processed by the crude drug of following parts by weight:
Radix Gentianae Macrophyllae 50-150 part, Radix Stephaniae Tetrandrae 50-150 part, Herba Taxilli 50-150 part, Ramulus Mori 200-400 part, Radix Rehmanniae 200-400 part, Semen pini koraiensis 50-150 part, Caulis Lonicerae 50-150 part.
2. according to the described rheumatoid arthritis Ramulus Mori of claim l Radix Rehmanniae Chinese medicine oral liquid, it is characterized in that: be to process by the crude drug of following parts by weight:
100 parts of Radix Gentianae Macrophyllae, 100 parts of Radixs Stephaniae Tetrandrae, 100 parts of Herba Taxillis, 300 parts of Ramulus Moris, 300 parts in the Radix Rehmanniae, 100 parts of Semen pini koraiensis, 100 parts of Caulis Loniceraes.
3. according to the described rheumatoid arthritis Ramulus Mori of claim l Radix Rehmanniae Chinese medicine oral liquid and method for preparing, it is characterized in that: comprise the following steps:
Get it filled 100 parts of material Radix Gentianae Macrophyllae, 100 parts of Radixs Stephaniae Tetrandrae, 100 parts of Herba Taxillis, 300 parts of Ramulus Moris, 300 parts in the Radix Rehmanniae, 100 parts of Semen pini koraiensis, 100 parts of Caulis Loniceraes, water decocts secondary, and the 8-10 that each water consumption is a medical material weight doubly measures, and decocts secondary; Each 1-2 hour, filter, filtrating is condensed into and surveys relative density at 60-65 ℃ is the clear paste of 1.10-1.25, to contain amount of alcohol be 60% to making to add ethanol; Stir, leave standstill, filter, get filtrate recycling ethanol; Be condensed into the extractum that contains solid weight 65-67%, add sucrose 20%, refined honey 12%, antiseptic 1-3%, stock solution embedding, irradiation sterilization; Packed products is processed oral liquid, promptly gets.
CN 201210182097 2012-06-04 2012-06-04 Mulberry twig and rehmannia root Chinese medicinal oral solution for relieving rheumatoid arthritis and preparation method of mulberry twig and rehmannia root Chinese medicinal oral solution Active CN102670833B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201210182097 CN102670833B (en) 2012-06-04 2012-06-04 Mulberry twig and rehmannia root Chinese medicinal oral solution for relieving rheumatoid arthritis and preparation method of mulberry twig and rehmannia root Chinese medicinal oral solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201210182097 CN102670833B (en) 2012-06-04 2012-06-04 Mulberry twig and rehmannia root Chinese medicinal oral solution for relieving rheumatoid arthritis and preparation method of mulberry twig and rehmannia root Chinese medicinal oral solution

Publications (2)

Publication Number Publication Date
CN102670833A true CN102670833A (en) 2012-09-19
CN102670833B CN102670833B (en) 2013-10-02

Family

ID=46803818

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201210182097 Active CN102670833B (en) 2012-06-04 2012-06-04 Mulberry twig and rehmannia root Chinese medicinal oral solution for relieving rheumatoid arthritis and preparation method of mulberry twig and rehmannia root Chinese medicinal oral solution

Country Status (1)

Country Link
CN (1) CN102670833B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103566024A (en) * 2013-10-24 2014-02-12 安徽工贸职业技术学院 Medicinal liquor for treating arthritis
CN103566021A (en) * 2013-10-24 2014-02-12 安徽工贸职业技术学院 Traditional Chinese medicine composition for treating rheumatic arthritis
CN105878834A (en) * 2016-04-22 2016-08-24 谢兴文 Ramulus Mori and Semen Coicis Chinese medicine composition with effects of clearing away heat and eliminating damp

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06107556A (en) * 1992-10-01 1994-04-19 Isukura Sangyo Kk Chinese analgesic composed exclusively of herb drug
CN101874851A (en) * 2009-04-29 2010-11-03 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic infectious arthritis
CN101979074A (en) * 2010-10-27 2011-02-23 苏桂华 Traditional Chinese medicine for treating rheumatoid arthritis
WO2011048221A1 (en) * 2009-10-22 2011-04-28 Bionorica Se Anti-inflammatory agent containing hydrolysates of plant extracts
JP2011256136A (en) * 2010-06-09 2011-12-22 Nihon Univ Collagen decomposition inhibitor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06107556A (en) * 1992-10-01 1994-04-19 Isukura Sangyo Kk Chinese analgesic composed exclusively of herb drug
CN101874851A (en) * 2009-04-29 2010-11-03 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating chronic infectious arthritis
WO2011048221A1 (en) * 2009-10-22 2011-04-28 Bionorica Se Anti-inflammatory agent containing hydrolysates of plant extracts
JP2011256136A (en) * 2010-06-09 2011-12-22 Nihon Univ Collagen decomposition inhibitor
CN101979074A (en) * 2010-10-27 2011-02-23 苏桂华 Traditional Chinese medicine for treating rheumatoid arthritis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103566024A (en) * 2013-10-24 2014-02-12 安徽工贸职业技术学院 Medicinal liquor for treating arthritis
CN103566021A (en) * 2013-10-24 2014-02-12 安徽工贸职业技术学院 Traditional Chinese medicine composition for treating rheumatic arthritis
CN105878834A (en) * 2016-04-22 2016-08-24 谢兴文 Ramulus Mori and Semen Coicis Chinese medicine composition with effects of clearing away heat and eliminating damp

Also Published As

Publication number Publication date
CN102670833B (en) 2013-10-02

Similar Documents

Publication Publication Date Title
CN102836177A (en) Traditional Chinese medicine preparation for treating osteopathia
CN105381329A (en) Traditional Chinese medicine for treating gout, rheumatism and soreness
CN103505659A (en) Chinese proprietary medicine for treating rheumatoid arthritis
CN102188571A (en) Medicament for treating gout
CN102670833B (en) Mulberry twig and rehmannia root Chinese medicinal oral solution for relieving rheumatoid arthritis and preparation method of mulberry twig and rehmannia root Chinese medicinal oral solution
CN103054965B (en) External analgesic plaster for treating arthralgia and preparation method of external analgesic plaster
CN1861171A (en) Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN102895610A (en) Medicine for treating edema
CN102600351B (en) Traditional Chinese medicine for treating pruritus cutanea
CN102526275B (en) Pharmaceutical for curing gout and preparation method thereof
CN101869676A (en) Medicinal liquor for treating cold and dampness
CN103735647A (en) Medicated wine for treating chronic infectious arthritis
CN101129697A (en) Orally taken traditional Chinese medicine composition for treating atrophic arthritis
CN102349957A (en) Traditional Chinese medicine composition for treating prurigo
CN101732507A (en) Formula of foot-soaking Chinese medicament for treating gout and preparation method thereof
CN105311210A (en) Pharmaceutical composition for treating rheumatoid bone diseases
CN102670717B (en) Tortoise shell Chinese medicine oral liquid for relieving chronic infectious arthritis and preparation method of same
CN103961490A (en) Compound medicine for treating wind-cold-dampness arthralgia and preparation method thereof
CN100363036C (en) Chinese medicine composition for treating diabets and preparing method
CN104161805A (en) Traditional Chinese medicine for treating femoral head necrosis, and preparation method thereof
CN102335304B (en) Chinese medicine composition for dispelling wind, removing dampness, invigorating blood circulation, and relieving pain and preparation method thereof
CN102641348B (en) Collateral-dredging and pain-relieving powder and preparation method thereof
CN102205102B (en) Chinese medical plantar pain-relieving ointment for treating plantar fasciitis
CN102488818B (en) Pharmaceutical composition for treating rheumatism and rheumatoid arthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: NANTONG WEEK TOURISM DEVELOPMENT CO., LTD.

Free format text: FORMER OWNER: HUANG YUN

Effective date: 20140416

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 523120 DONGGUAN, GUANGDONG PROVINCE TO: 226121 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20140416

Address after: Haimen City, Jiangsu province 226121 Nantong markets three factory town Road No. 79

Patentee after: Nantong seven Tourism Development Co., Ltd.

Address before: 523120 A elegant department store, Dongcheng style walking street, Dongguan, Dongcheng District, Guangdong

Patentee before: Huang Yun